SCRI’s Contract Research Organization: the premier partner of choice.

SCRI Logo

SCRI Logo

The contract research organization (CRO) model of today requires an ever-evolving approach to address increasing demands – from FDA requirements for diversity plans for clinical trial participation to growing requests for supporting efficient clinical trial design and the availability of high-quality data for rapid analysis – all while maintaining the goal of producing clinically meaningful results.

Learn about how SCRI Development Innovations is uniquely positioned to make an impact.

Optimizing the CRO model to address the industry’s ever-changing landscape.

SCRI Development Innovations, our global, full-service CRO, offers end-to-end capabilities fully dedicated to oncology – from first-in-human studies to regulatory approval. Our patients are at the center of every decision we make. We have a long history and proven track record of partnering with biopharma companies to design, manage and monitor Phase 1 through Phase 4 clinical trials and analyze the results to advance therapies for people facing cancer.

SCRI Development Innovations leverages the expertise of globally recognized oncologists to design and implement clinical trials.

Through Accelero, we work in tandem with our centralized Site Management Organization (SMO) to design and deliver timely site activation, patient recruitment and overall study delivery. This enhanced collaboration enables efficiencies that accelerate drug development and optimize clinical trial operations.

Our Personalized Medicine program, powered by precision medicine technology from Genospace, offers scientific consultative services to our biopharma partners to inform clinical development approaches every step of the way and enrich clinical development insights.

Partner with Us

Optimizing the CRO model to address the industry’s ever-changing landscape.

SCRI Development Innovations, our global, full-service CRO, offers end-to-end capabilities fully dedicated to oncology – from first-in-human studies to regulatory approval. Our patients are at the center of every decision we make. We have a long history and proven track record of partnering with biopharma companies to design, manage and monitor Phase 1 through Phase 4 clinical trials and analyze the results to advance therapies for people facing cancer.

SCRI Development Innovations leverages the expertise of globally recognized oncologists to design and implement clinical trials.

Through Accelero, we work in tandem with our centralized Site Management Organization (SMO) to design and deliver timely site activation, patient recruitment and overall study delivery. This enhanced collaboration enables efficiencies that accelerate drug development and optimize clinical trial operations.

Our Personalized Medicine program, powered by precision medicine technology from Genospace, offers scientific consultative services to our biopharma partners to inform clinical development approaches every step of the way and enrich clinical development insights.

Partner with Us
 

Three people looing at a some reports

A person looking into a microscope.

We have been providing CRO services in oncology since 2006.

 

The contract research organization (CRO) model of today requires an ever-evolving approach to address increasing demands – from FDA requirements for diversity plans for clinical trial participation to growing requests for supporting efficient clinical trial design and the availability of high-quality data for rapid analysis – all while maintaining the goal of producing clinically meaningful results.

Learn about how SCRI Development Innovations is uniquely positioned to make an impact.

A person looking into a microscope.

We have been providing CRO services in oncology since 2006.

The contract research organization (CRO) model of today requires an ever-evolving approach to address increasing demands – from FDA requirements for diversity plans for clinical trial participation to growing requests for supporting efficient clinical trial design and the availability of high-quality data for rapid analysis – all while maintaining the goal of producing clinically meaningful results.

Learn about how SCRI Development Innovations is uniquely positioned to make an impact.

Proven Performance

395+

trials conducted to date, including both industry-sponsored and investigator-initiated trials

70+

first-in-human trials conducted

25+

first-in-class trials conducted

395+

trials conducted to date, including both industry-sponsored and investigator-initiated trials

70+

first-in-human trials conducted

25+

first-in-class trials conducted

Our expert scientists manage clinical data throughout a study's lifecycle. They advance therapeutic assets from concept to clinical development, identify target patient profiles, consult key opinion leaders, and enhance trial efficiencies.
Our team of medical professionals and experienced oncology physicians ensures the successful implementation and maintenance of safety strategies and processes. They handle enrollment approval, address protocol and site questions, and provide input on safety requirements for drug development across all oncologic areas and trial phases.
With nearly four decades of clinical trial experience, our team authors essential documents for drug development, including protocols, consent forms, regulatory submissions, scientific publications, and patient educational materials.
Our expert team of safety leads, scientists and physicians ensures patient safety with customizable solutions, including Safety Monitoring Plans, Oracle Argus database, case processing, ongoing safety data review, signal detection, and periodic safety reports (DSUR).
With over 30 years of experience, our team handles authority and IRB submissions for clinical trials in the U.S., Canada, and the U.K.
Our cross-functional teams will collaborate to plan an efficient method for executing your trial. We'll anticipate and mitigate study challenges, maintaining a nimble approach for rapid decision-making to achieve your milestones.
Our clinical monitoring team, comprising trained clinical research associates with oncology and early phase expertise, conducts remote and on-site visits across North America and globally. Experienced in 100% and reduced SDV models, our CRAs oversee data integrity, manage sites, and support regulatory compliance to produce high-quality data.
Our team offers services during start-up, maintenance, and close-out. At each phase, our experienced team follows rigorous processes to provide quality data management and biostatistics services, ensuring clean data, continuous review, regulatory compliance, and final deliverables for our sponsors.
Our Clinical Affairs team collaborates with participating sites to ensure a smooth and seamless study experience, while our Project Managers ensure all the moving parts of the study come together for an efficient and cohesive experience for our patients.

We have proven expertise in numerous areas of oncology research.

Biopharma partners have access to our full scope of CRO services:
top